4D Molecular Therapeutics

#WetAMD is a chronic disease, and many #patients require long-term, frequent injections directly into the eye.    We believe our #GeneticMedicine candidate, 4D-150, has the potential to address the treatment burden and progressive vision loss associated with wet AMD. Learn more: https://lnkd.in/ghisB4z5   #Ophthalmology

Millions of individuals live with #wetAMD today with a high risk of permanent vision loss, and those affected only continues to grow as our society ages.    We are more determined than ever to help these patients preserve their vision by addressing the significant limitations of current therapeutic regimens.    Learn how our #GeneticMedicines can potentially redefine the treatment paradigm for large market #ophthalmic diseases: https://lnkd.in/eKU5H4M3

Last weekend, members of our team attended #AAO2024 to engage with leading experts in #ophthalmology and share the latest insights and innovations from the forefront of our work at 4DMT.    Thank you to everyone who connected with us on-site!    American Academy of Ophthalmology

Last week, our team had the honor of attending Emily's Entourage Gala, an inspiring event dedicated to fundraising for research and drug development for the final 10% of people with #CysticFibrosis that do not benefit from currently available mutation-targeted therapies. We are proud to contribute to this vital cause and are ecstatic to hear about the $1.34 million raised from this year’s “Efflorescence” gala to pave the way for innovative research that could change the lives of those living with CF. #EEfflorescence #CureCF

Our Ophthalmology Advisory Board Member, Anat Loewenstein, M.D., MHA, was recently featured in a Healio | Ocular Surgery News Video Perspective following this year’s European Society of Retina Specialists (EURETINA) congress, where she dives into the latest #data from our Phase 1/2 PRISM study evaluating 4D-150 in #wetAMD.    Watch the full video to hear about 4D-150’s continued progress and its potential to stabilize disease for #patients without the need for frequent injections: https://bit.ly/3BL1k5q    #geneticmedicines #EURETINA2024

Last month, Melissa Calton, Ph.D., presented preclinical data on our aerosolized #GeneticMedicine, 4D-710, for #CysticFibrosis (CF) at the 2024 North American Cystic Fibrosis Conference (#NACFC). We enjoyed connecting with a diverse group of researchers, clinicians, and advocates dedicated to improving the lives of those affected by CF.

Based on data to date, 4D-150 has the potential to treat wet AMD and decrease the prevalent treatment burden of standard of care with a safe, single routine intravitreal injection while maintaining vision and retinal anatomy. Hear from our Chief Development Officer, Dhaval B. Desai, who summarizes our confidence in 4D-150's #wetAMD data that is shaping 4FRONT, our Phase 3 global development program. #ophthalmology #retina

Congrats to our CEO, David Kirn, MD, on being named a 2024 #PharmaVoice100 recipient!   This award recognizes the most inspiring people in the life science industry who are known for pioneering new paths and lifting their companies to new heights. Beyond Dr. Kirn’s impressive accomplishments within the industry today, he is also dedicated to mentoring the next generation of leaders, ensuring that the future of biotech is in capable hands.   Read the full feature here: https://lnkd.in/e9pFrenZ

Tomorrow, our Chief Research & Translational Development Officer, An Song, Ph.D., will be delivering a corporate presentation at the Meeting on the Mesa in Phoenix, Arizona. Join us as we share our latest insights and innovations!   #CGMesa24 #MeetingontheMesa

We look forward to attending this year’s Emily’s Entourage Gala, celebrating 13 incredible years of advocacy and progress in the fight against #CysticFibrosis!   This year's theme, Efflorescence, symbolizes the journey of growth and blossoming into a new era of hope for the final 10% of the CF community who do not benefit from mutation-targeted therapies. We are proud of the work that we have done to advance innovative therapies for those in need.    #EEFLORESCENCE